Separating and purifying method for new recombinant human interferon alpha2b
A technology for the separation and purification of recombinant human interferon, applied in the field of separation and purification of recombinant human interferon α2b, can solve the problems of difficult separation and purification, many separation and purification steps, poor pressure resistance of chromatographic media, etc., and achieve the effect of smooth process flow
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0027] primary interferon
[0028] 1. TE washing
[0029] Take out the cells, dissolve them quickly in running water, add pre-cooled TE solution, stir well, centrifuge at 4000 rpm at 4°C for 20 minutes, discard the supernatant and keep the precipitate.
[0030] 2. Ultrasonic bacteria destruction:
[0031] Put the suspended bacterial solution in an ice bath environment, 1 minute / time, with an interval of 1 minute, and sonicate 25-30 times. Microscopic examination, the bacteria destruction rate should be greater than 98%. Add the pre-cooled TE solution according to the weight of the engineered bacteria at a ratio of 1:5 (weight / volume), stir well, centrifuge at 10,000 rpm at 4°C for 20 minutes, discard the supernatant, and weigh the precipitate.
[0032] 3. Urea dissolution:
[0033] Add the precipitate to the pre-cooled 4M urea / TE solution at a ratio of 1:10 (weight / volume), pipette evenly, centrifuge at 10,000 rpm at 4°C for 25 minutes, discard the supernatant and save the...
Embodiment 2
[0090] This clinical trial proves that the safety and anti-HBV curative effect of the recombinant human interferon α2b for injection developed by this process are equivalent to those produced by the original process. There is no significant difference in curative effect between the two, and both have good safety.
[0091] The clinical protocol and data are as follows:
[0092] In this study, a multi-center, randomized double-blind, positive drug parallel control test method was adopted. The recombinant human a-2b interferon for injection produced by the original technology of Beijing Kaiyin Biotechnology Co., Ltd. was used as a control to evaluate the company's new technology. Safety and efficacy of recombinant human alpha-2b interferon for injection in the treatment of HBeAg-positive chronic hepatitis B patients. There were 225 cases in the ITT population, 20 cases dropped out, and the drop-out rate was 8.88%. There were 205 cases in the PP population, of which 205 cases (91....
Embodiment 3
[0100] This stability test confirms that the stability of the product produced by the process of the present invention meets the quality requirements.
[0101] method:
[0102] 1. Stability key inspection items: appearance, solubility, clarity, biological activity, pH value of the finished product
[0103] Other testing items: sterility test, moisture.
[0104] (1) Measuring methods for appearance, solubility and clarity of finished products: see Appendix IX A and B of the Pharmacopoeia of the People's Republic of China and Regulations for Biological Products of China
[0105] (2) Biological activity assay method: Cytopathic inhibition method, Wish cell / VSV as detection system. Calibrated with national reference standards.
[0106] (3) pH value determination method: see "Pharmacopoeia of the People's Republic of China" Appendix VI H
[0107] (4) Sterility test: refer to item A of the general rule "Biological Products Sterility Test Regulations" of "China Regulations for Biol...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com